Literature DB >> 12946270

Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties.

Lourdes Rodrigo1, Fernando Gil, Antonio F Hernandez, Olga Lopez, Antonio Pla.   

Abstract

Three paraoxonase genes (PON1, PON2 and PON3) have been described so far in mammals. Although considerable information is available regarding PON1, little is known about PON2 and PON3. PON3 has been isolated recently from rabbit serum [Draganov, Stetson, Watson, Billecke and La Du (2000) J. Biol. Chem. 275, 33435-33442] and liver [Ozols (1999) Biochem. J. 338, 265-275]. In the present study, we have identified the presence of PON3 in rat liver microsomes and a method for the purification to homogeneity is presented. PON3 has been purified 177-fold to apparent homogeneity with a final specific activity of 461 units/mg using a method consisting of seven steps: solubilization of the microsomal fraction, hydroxyapatite adsorption, chromatography on DEAE-Sepharose CL-6B, non-specific affinity chromatography on Cibacron Blue 3GA, two DEAE-cellulose steps and a final affinity chromatography on concanavalin A-Sepharose. SDS/PAGE of the final preparation indicated a single protein-staining band with an apparent molecular mass of 43 kDa. The isolated protein was identified by nanoelectrospray MS. Internal amino acid sequences of several peptides were determined and compared with those of human, rabbit and mouse PON3, showing a high similarity. Some biochemical properties of PON3 were also studied, including optimum pH, K(m) and heat and pH stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946270      PMCID: PMC1223763          DOI: 10.1042/BJ20030732

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Purification and characterization of paraoxon hydrolase from rat liver.

Authors:  L Rodrigo; F Gil; A F Hernandez; A Marina; J Vazquez; A Pla
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

Authors:  L W Castellani; M Navab; B J Van Lenten; C C Hedrick; S Y Hama; A M Goto; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

4.  The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.

Authors:  H G Davies; R J Richter; M Keifer; C A Broomfield; J Sowalla; C E Furlong
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

5.  Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases.

Authors:  Y Imai; H Morita; H Kurihara; T Sugiyama; N Kato; A Ebihara; C Hamada; Y Kurihara; T Shindo; Y Oh-hashi; Y Yazaki
Journal:  Atherosclerosis       Date:  2000-04       Impact factor: 5.162

6.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Authors:  S L Primo-Parmo; R C Sorenson; J Teiber; B N La Du
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

7.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

8.  Comparison of purified human and rabbit serum paraoxonases.

Authors:  C L Kuo; B N La Du
Journal:  Drug Metab Dispos       Date:  1995-09       Impact factor: 3.922

9.  Differences in the kinetic properties, effect of calcium and sensitivity to inhibitors of paraoxon hydrolase activity in rat plasma and microsomal fraction from rat liver.

Authors:  F Gil; M C Gonzalvo; A F Hernandez; E Villanueva; A Pla
Journal:  Biochem Pharmacol       Date:  1994-10-18       Impact factor: 5.858

10.  Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase.

Authors:  R C Sorenson; S L Primo-Parmo; C L Kuo; S Adkins; O Lockridge; B N La Du
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  7 in total

Review 1.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

2.  Impact of antibacterial drugs on human serum paraoxonase-1 (hPON1) activity: an in vitro study.

Authors:  Hakan Söyüt; Elif Duygu Kaya; Sükrü Beydemir
Journal:  Asian Pac J Trop Biomed       Date:  2014-08

3.  Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat.

Authors:  Rita Romani; Gianna Evelina De Medio; Simona di Tullio; Rosa Lapalombella; Irene Pirisinu; Vittoria Margonato; Arsenio Veicsteinas; Marina Marini; Gabriella Rosi
Journal:  J Lipid Res       Date:  2008-12-16       Impact factor: 5.922

Review 4.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

5.  Effect of pre-germinated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats.

Authors:  Seigo Usuki; Yukihiko Ito; Keiko Morikawa; Mitsuo Kise; Toshio Ariga; Michael Rivner; Robert K Yu
Journal:  Nutr Metab (Lond)       Date:  2007-11-23       Impact factor: 4.169

Review 6.  Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease.

Authors:  Kumari Priyanka; Surjit Singh; Kirandip Gill
Journal:  Biomolecules       Date:  2019-12-03

Review 7.  A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease.

Authors:  Chrysan J Mohammed; Sabitri Lamichhane; Jacob A Connolly; Sophia M Soehnlen; Fatimah K Khalaf; Deepak Malhotra; Steven T Haller; Dragan Isailovic; David J Kennedy
Journal:  Antioxidants (Basel)       Date:  2022-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.